These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34919024)

  • 1. Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway.
    Niu R; Li D; Chen J; Zhao W
    Cell Cycle; 2022 Jan; 21(1):86-100. PubMed ID: 34919024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_0091537 promotes gefitinib chemoresistance in non-small cell lung cancer by mediating the miR-520h/YAP1 network.
    Qu R; Ma J
    Anticancer Drugs; 2023 Nov; 34(10):1151-1161. PubMed ID: 36727737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer.
    Sheng J; Liu L; Dong T; Wu X
    J Chemother; 2022 Oct; 34(6):401-413. PubMed ID: 34861803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel circ_MACF1/miR-942-5p/TGFBR2 axis regulates the functional behaviors and drug sensitivity in gefitinib-resistant non-small cell lung cancer cells.
    Fan D; Yang Y; Zhang W
    BMC Pulm Med; 2022 Jan; 22(1):27. PubMed ID: 34996416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0001786 facilitates gefitinib resistance and malignant progression in non-small cell lung cancer via miR-34b-5p/SRSF1.
    Ouyang K; Xie D; Liao H; He Y; Xiong H
    J Cardiothorac Surg; 2024 Apr; 19(1):178. PubMed ID: 38581057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0006988 promotes the proliferation, metastasis and angiogenesis of non-small cell lung cancer cells by modulating miR-491-5p/MAP3K3 axis.
    Yang C; Shi J; Wang J; Hao D; An J; Jiang J
    Cell Cycle; 2021 Jul; 20(13):1334-1346. PubMed ID: 34189997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0001955 promotes the progression of non-small cell lung cancer via miR-769-5p/EGFR axis.
    Ding L; Feng Y; Li L
    Cell Cycle; 2022 Nov; 21(22):2433-2443. PubMed ID: 35920610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non-small-cell lung cancer cells by regulating the miR-526b-5p/GRK5 axis.
    Liu Y; Li C; Liu H; Wang J
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00812. PubMed ID: 34219377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
    Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
    Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0074027 Contributes to Non-Small Cell Lung Cancer Progression by Upregulating
    Yu C; Ying J; Yu K; Shen W; Jiang M
    Cancer Biother Radiopharm; 2022 Mar; 37(2):73-83. PubMed ID: 32580576
    [No Abstract]   [Full Text] [Related]  

  • 11. Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC).
    Hong W; Xue M; Jiang J; Zhang Y; Gao X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):149. PubMed ID: 32746878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
    Tan Z; Cao F; Jia B; Xia L
    Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer.
    Chang F; Li J; Sun Q; Wei S; Song Y
    Bioengineered; 2022 Apr; 13(4):8806-8822. PubMed ID: 35287543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_0001658 regulates gefitinib resistance of non-small cell lung cancer through miR-409-3p/TWIST1 axis.
    Yu X; Fu X; Zhang X; Bai C; Wang Y
    Anticancer Drugs; 2022 Feb; 33(2):158-166. PubMed ID: 34694278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0000514 promotes the malignant biological behaviors of non-small cell lung cancer cells by modulating miR-330-5p and HMGA2.
    Jia L; Liu M; An L; Wang H; Wang X
    Pathol Res Pract; 2022 Jul; 235():153913. PubMed ID: 35552087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ-PITX1 promotes non-small-cell lung cancer progression through regulating ETS1 expression via miR-615-5p.
    Guo Y; Pan J; Gao X; Zheng Y
    Thorac Cancer; 2024 Sep; 15(27):1946-1957. PubMed ID: 39138880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer.
    Li J; Xu J; Wu G; Ren Y; Wang X; Zhang Q
    Chemotherapy; 2022; 67(4):223-233. PubMed ID: 35649347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA hsa_circ_0004396 acts as a sponge of miR-615-5p to promote non-small cell lung cancer progression and radioresistance through the upregulation of P21-Activated Kinase 1.
    Li D; Yan L; Zhang J; Gu F
    J Clin Lab Anal; 2022 Jun; 36(6):e24463. PubMed ID: 35500159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circ_0000376 promotes paclitaxel resistance and tumorigenesis of non-small cell lung cancer via positively modulating KPNA4 by sponging miR-1298-5p.
    Hu S; Zhang Q; Sun J; Xue J; Wang C
    Thorac Cancer; 2023 Aug; 14(22):2116-2126. PubMed ID: 37455373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0011292 Enhances Paclitaxel Resistance in Non-Small Cell Lung Cancer by Regulating miR-379-5p/TRIM65 Axis.
    Guo C; Wang H; Jiang H; Qiao L; Wang X
    Cancer Biother Radiopharm; 2022 Mar; 37(2):84-95. PubMed ID: 32833503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.